Analystreport

REDHILL BIOPHAR/S (NASDAQ: RDHL) was upgraded by analysts at ValuEngine from a "sell" rating to a "hold" rating.

Redhill Biopharma Ltd. - American Depositary Shares  (RDHL) 
US:NASDAQ Investor Relations: ir.redhillbio.com/investor-relations